RxDoctor Payments Data

Stephen Dreskin, MD

Pain Medicine · Chattanooga, TNNPI 1386648160

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Scilex Pharmaceuticals Inc. at 39.7% of the total. Reporting peaked in 2024 at $699 and has fallen 53.0% since, to $328 in 2025. That places this record below the midpoint for pain medicine clinicians in TN, where the typical reported total is $2,322.

$1,912in general payments, 2019–2025

Across 85 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$759
  • Boston Scientific$312
  • AbbVie$270
  • Medtronic$214
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$91
  • Pfizer$79
  • plus $188 from 9 others

What the payments were for

  • Food & beverage$1,912100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,912 in reported general payments places this provider in the 45th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$340,524
Medicare patients
672
Services billed
3,570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,462$31,557
ZtlidoLidocaine19$16,115
Gabapentin942$15,161
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen732$14,697
LinzessLinaclotide22$11,359
Pregabalin461$11,250
SavellaMilnacipran Hcl13$6,160
Duloxetine Hcl430$5,624
Diclofenac Sodium40$2,689
Topiramate291$2,640
Oxycodone Hcl185$2,548
Tizanidine Hcl209$1,981
Lidocaine33$1,897
Tramadol Hcl269$1,507
Baclofen66$1,177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Savella$270$17,51935 claims
Scilex Pharmaceuticals Inc.Ztlido$759$16,11519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 112 pain medicine providers in Tennessee.

Other pain medicine in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →